Post-warranty Preventive Maintenance and Repair Services on a Bruker Biotyper MALDI Mass Spectrometer
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA), specifically the Center for Biologics Evaluation and Research (CBER) / Office of Vaccines Research and Review (OVRR), has issued a Combined Synopsis/Solicitation (RFQ) for Post-warranty Preventive Maintenance and Repair Services for a Bruker Biotyper MALDI Mass Spectrometer. This instrument is critical for high-throughput bacterial identification experiments at their Silver Spring, MD facility. The opportunity is for full and open competition under NAICS 811210. Quotes are due by June 25, 2026, at 1:00 PM Central Time.
Scope of Work
The required services include comprehensive maintenance and repair for the Bruker Biotyper MALDI Mass Spectrometer. Key deliverables are:
- Preventive Maintenance: Two (2) scheduled on-site visits annually, including all necessary parts.
- Corrective Maintenance: Unlimited on-site repairs within two business days of a service call, if remote resolution is not possible.
- Personnel & Parts: Services must be performed by OEM-trained and certified engineers using OEM-certified replacement parts.
- Technical Support: Access to OEM technical developments, repair procedure bulletins, unlimited software/firmware/application updates, and unlimited phone/email technical support (Monday-Friday, 8:00 AM - 5:00 PM ET).
- Reporting: Service records/reports for each call and a summary report to the FDA COR and Contract Specialist.
Contract Details
- Contract Type: Firm Fixed Price.
- Period of Performance: A base year from August 1, 2026, to July 31, 2027, followed by two (2) one-year option periods. The total contract duration, including options, will not exceed three years.
- Place of Performance: Silver Spring, MD.
- Set-Aside: Full and Open Competition.
- NAICS Code: 811210 - Electronic and Precision Equipment Repair and Maintenance, with a small business size standard of $34 million.
Submission & Evaluation
This is a Request for Quote (RFQ), and a separate written solicitation will not be issued. Offerors must provide sufficient technical information to demonstrate their capability to meet or exceed all requirements.
- Evaluation Factors: Technical Capability and Past Performance are considered equally important and, collectively, more important than price. Past performance should be recent (within the last three years) and relevant.
- Price Submission: Detailed pricing reflecting the offeror's response to the schedule is required.
- Submission Requirements: Include Unique Entity ID (UEI) number. Quotes must be submitted via email to warren.dutter@fda.hhs.gov.
- Deadline: Quotes are due by June 25, 2026, at 1:00 PM Central Time. Offerors must hold prices firm through September 30, 2026.
Additional Notes
The solicitation incorporates FAR clauses by reference. Offerors are advised that electronic submissions must not contain macros, as such submissions will be considered non-responsive. Information regarding Section 508 accessibility standards is also included. The Bruker Biotyper MALDI Mass Spectrometer is currently not under a service contract.